US Patent Issued to Merck Sharp & Dohme on Feb. 3 for "Preparation of tetrahydroindazole derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors" (New Jersey, California Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,132, issued on Feb. 3, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Preparation of tetrahydroindazole derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors" was invented by Jianming Bao (Princeton, N.J.), Chen Cheng (Millbrae, Calif.), Faben A. Cruz (Burlingame, Calif.), Yeon-Hee Lim (South San Francisco, Calif.), Cedric L. Hugelshofer (Oakland, Calif.), Jinlong Jiang (Scotch Plains, N.J.), Victor W. Mak (South San Francisco, Calif.) and Emma Helen Southgate (Mountain View, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Invented are compounds of formula I and the pharmaceutically acceptable salts, esters, and prodrugs...